President

Mr. Ranga R. Iyer
Managing Director
Wyeth Ltd

Mr. Ranga Iyer is the President of OPPI & Managing Director of Wyeth Limited. He joined Wyeth in 1980 and rose to become its Managing Director in the year 2000. Before becoming Managing Director, he has held various positions of increasing responsibilities in Finance and other Commercial functions. Mr. Iyer was the Vice-President of OPPI. He is also the Managing Committee Member of Bombay Chamber of Commerce and Industry and Advisory Council Member of Narsee Monjee Institute of Management Studies for MBA in Pharmaceuticals. Mr. Iyer holds a Post Graduate degree in Commerce and MBA in Finance from Bombay University.
 

Vice Presidents

Dr. Girish L. Telang is the Vice-President of OPPI & Managing Director of Roche Scientific Company (India) Pvt. Ltd. Dr. Telang is a medical graduate from Grant Medical College, University of Bombay and has also undergone post-graduate training in nuclear medicine during his five year stint in the Medical Corps of the Indian Army. He also holds a Diploma in Advertising Management. Dr. Telang has been with Roche for over 28 years and during this time he has held positions in Clinical Research, Corporate Communications, Medico Marketing and Head of the Pharmaceutical Division. He is the Chairman of the Medical Committee of OPPI.
 

Kewal Handa is Managing Director, Pfizer Limited, the world’s No.1 pharmaceutical company that discovers and develops break-through drugs, provides information on prevention, wellness, and treatment; consistent high-quality manufacturing of medicines, consumer products; and is a global leader in corporate responsibility. Under his leadership, the company is now aggressive in its growth plans and has launched several new products.

Kewal is a reputed industry expert who takes the lead on key issues that concern the pharmaceutical sector. As Vice President of the Organisation of Pharmaceutical Producers of India (OPPI), he has been at the forefront of the industry’s efforts to resolve issues pertaining to the pharmaceutical sector. He has recently been appointed as the President of All India Management Association and is a committee member of various industry bodies in the country.

Kewal was awarded the ‘India CFO 2004 – Excellence in Finance in an MNC’ by International Market – Assessment Group and has recently won the Bharat Shiromani Award.

A qualified Management Accountant and Company Secretary, and with a Masters Degree in Commerce from Sydenham College, Mumbai, Kewal has completed the Pfizer Leadership Development Program from Harvard University, the Senior Management Development Program from IIM, Ahmedabad. He has also done a course on Marketing Strategy from Columbia Business School.

 

Dr. Shailesh Ayyangar is the Vice-President of OPPI & Managing Director, Aventis Pharma Ltd., Sanofi Aventis Group. Dr. Ayyangar is a topper is the Post Graduate Programme in Business Management from the Indian Institute of Management, Ahmedabad (IIMA). He started his career with Ranbaxy and then moved on to Eskayef Ltd. (SmithKline Beecham) and later became the Vice President – Sales Operations for Pharmaceuticals for SmithKline Beecham. Later on, Dr. Ayyangar was selected to direct the International Tropical Medicine Initiative of SmithKline Beecham in U.K. He returned to India in 2000 to oversee the merger of SmithKline Beecham commercial operations with GlaxoWellcome and subsequent to the merger he took over as Executive Vice President, Sales and Marketing in GlaxoSmithKline in India. In 2002, he left GSK to take over as Managing Director of Sanofi-Synthelabo operations in India. He is the Chairman of Sales Force Effectiveness Committee of OPPI.
 

Dr. Hasit Joshipura is the Vice-President & also the Chairman of Communications & PR Committee of OPPI. He is Vice President, South Asia and Managing Director, India, GlaxoSmithKline Pharmaceuticals Ltd. (GSK). He is also Chairman on the boards of GSK Bangladesh and GSK Sri Lanka. Prior to this, Dr. Joshipura was President & Executive Director of Johnson & Johnson Ltd. from October 2001 to August 2006. Dr. Joshipura was the Chairperson for J&J’s Corporate Contributions Programme as well as the lead for Government Affairs for the J&J group of businesses in India. He worked with Tata Administrative Services and Unilever Group of companies. Dr. Joshipura is a graduate in Electrical Engineering from VJTI, Bombay University and a Post Graduate from Indian Institute of Management, Ahmedabad. He has been recently nominated by the Board of Governors VJTI to their Senate.
 

Director General

Mr. Tapan Ray
Director General, OPPI

Mr. Ray has around thirty years of national and international experience in the Healthcare Industry with Pharmaceuticals, Medical Diagnostics, Biotech, Neutraceutical/Cosmeceutical, Nutritional and Hospital Products business, based in India and the UK.

Mr. Ray has held various senior positions like:

• International Marketing Strategy Manager, Glaxo plc, U.K

• Director in the Board of Glaxo India Limited

• Non-Executive Director of Biddle Sawyer India Limited

• Managing Director of Abbott Laboratories India Limited

• Managing Director of Kopran Limited, India

• CEO and Director of Sami Labs Limited, India

Mr. Ray was also the President and Vice-President of the Organization of Pharmaceutical Producers of India (OPPI) and the Chairman of its Marketing Committee. He was the member of the National Drugs and Pharmaceutical Committee of the Confederation of Indian Industries (CII) and the Life Member of Bombay Management Association.

Mr. Ray also holds the position of:

• Member of the Board of World Self-Medication Industry, France

• Member of the Advisory Board of Institute of Intellectual Property Studies, Mumbai

• Visiting Faculty in India’s Top Management Institutes and a Key note Speaker in various National and Inter-national seminars and conferences.

Mr. Ray holds a B.Sc (Honors) and a Masters Degree in Geology from the University of Calcutta and has been a National Scholar.